Kurs
-0,75%
Likviditet
0,06 MEUR
Kalender
| Est. tid* | ||
| 2025-11-06 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-07 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-14 | N/A | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2025-05-06 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-08 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-13 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2024-05-10 | - | Årsstämma |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-03 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-04 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-11 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2023-05-10 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | Kvartalsrapport 2022-Q3 |
| 2022-09-06 | - | Extra Bolagsstämma 2022 |
| 2022-08-04 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2022-05-10 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-05 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-29 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2021-04-28 | - | Årsstämma |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-25 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-12 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2020-06-11 | - | Årsstämma |
| 2020-05-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Small Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Optomed PlcStock Exchange Release6 July 2022 at 8.30, Helsinki
Changes in Optomed's Leadership Team
Optomed's Vice President, Marketing and member of the leadership team Niina Huikuri has notified the Company that she will leave Optomed 30 September to pursue other opportunities.
"Niina has contributed significantly to our products launches and brand building in all of our key markets. We would like to thank Niina for excellent work and wish her the best of luck in her future endeavours" says Seppo Kopsala, the CEO of Optomed.
Optomed Plc
Further enquiries
Seppo Kopsala, CEO, Optomed Plc, seppo.kopsala@optomed.com
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.
www.optomed.com